Monday, October 1, 2018

Bacterial therapy tolerable, shows early promise in patients with advanced solid tumors

A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid tumor malignancies, according to new data.

from Top Health News -- ScienceDaily https://ift.tt/2QmSzBG
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

New MRI breakthrough reveals the brain and eye like never before

Scientists have redesigned a key piece of MRI hardware using metamaterials, allowing existing scanners to produce clearer images of difficul...